NYSE:HQL Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free HQL Stock Alerts $12.97 +0.02 (+0.15%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$12.96▼$13.0350-Day Range$12.79▼$14.1052-Week Range$11.34▼$14.37Volume165,031 shsAverage Volume112,066 shsMarket Capitalization$354.73 millionP/E RatioN/ADividend Yield10.25%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Abrdn Life Sciences Investors alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About Abrdn Life Sciences Investors Stock (NYSE:HQL)Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Read More HQL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQL Stock News HeadlinesApril 24, 2024 | insidertrades.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 2,022 Shares of StockApril 23, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $1,046,246.40 in StockApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 24, 2024 | americanbankingnews.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 2,022 Shares of StockMarch 21, 2024 | finance.yahoo.comabrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team UpdateMarch 8, 2024 | msn.comSYRA: Takeaways from Life Science Investor Forum PresentationMarch 1, 2024 | bizjournals.comA 2024 life sciences outlook in Boston – and beyondFebruary 9, 2024 | markets.businessinsider.comabrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in...April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? January 24, 2024 | benzinga.comPeering Into Anavex Life Sciences's Recent Short InterestNovember 23, 2023 | money.usnews.comabrdn Life Sciences InvestorsNovember 2, 2023 | investing.comAbrdn Life Sciences Investors (HQL)September 26, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...September 21, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...August 15, 2023 | seekingalpha.comTekla Life Sciences declares $0.32 dividendJune 20, 2023 | finance.yahoo.comabrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUMMay 17, 2023 | msn.comTekla Life Sciences Investors (HQL) Declares $0.32 DividendMay 15, 2023 | msn.comTekla Life Sciences dividend declines by 3% to $0.32March 21, 2023 | seekingalpha.comHQL Tekla Life Sciences InvestorsNovember 18, 2022 | msn.comTekla Life Sciences: Dividend InsightsNovember 2, 2022 | fool.comTekla Life Sciences Investors (NYSE: HQL)July 14, 2022 | seekingalpha.comHQL: A Biotechnology Equity CEF With No LeverageJune 8, 2022 | news.yahoo.comTekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear CapsuleMay 17, 2022 | seekingalpha.comTekla Life Sciences cuts dividend by 10% to $0.35April 27, 2022 | seekingalpha.comHQL: Buy For The Yield, If You Can Stomach The DepreciationFebruary 11, 2022 | seekingalpha.comTekla Life Sciences Investors: Buy For Steady, Quarterly DividendJanuary 18, 2022 | nasdaq.comTekla Life Sciences Investors Shares Approach 52-Week Low - Market MoverSee More Headlines Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/28 Dividend2/21/2024Dividend Payable3/28/2024Today4/26/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Investment offices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:HQL CUSIPN/A CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares27,350,000Free Float24,599,000Market Cap$354.73 million OptionableNot Optionable Beta0.71 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Daniel R. Omstead M.S (Age 71)Ph.D., Principal Executive Officer, President and Trustee Mr. Peter BrannerChief Investment OfficerKey CompetitorsSource CapitalNYSE:SORPutnam Premier Income TrustNYSE:PPTBarings Corporate InvestorsNYSE:MCITortoise Energy InfrastructureNYSE:TYGBlackRock MuniYield Michigan Quality FundNYSE:MIYView All CompetitorsInsiders & InstitutionsEudaimonia Partners LLCBought 10,434 shares on 4/25/2024Ownership: 0.038%Saba Capital Management, L.P.Bought 20,529 shares on 4/24/2024Total: $269,340.48 ($13.12/share)Blue Bell Private Wealth Management LLCBought 21,369 shares on 4/24/2024Ownership: 0.120%Raymond James Financial Services Advisors Inc.Bought 27,012 shares on 4/23/2024Ownership: 0.603%Saba Capital Management, L.P.Bought 2,022 shares on 4/22/2024Total: $26,043.36 ($12.88/share)View All Insider TransactionsView All Institutional Transactions HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed in 2024? Abrdn Life Sciences Investors' stock was trading at $13.46 at the start of the year. Since then, HQL stock has decreased by 3.6% and is now trading at $12.97. View the best growth stocks for 2024 here. Are investors shorting Abrdn Life Sciences Investors? Abrdn Life Sciences Investors saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 19,100 shares, a drop of 10.3% from the March 31st total of 21,300 shares. Based on an average daily volume of 110,600 shares, the days-to-cover ratio is presently 0.2 days. View Abrdn Life Sciences Investors' Short Interest. How often does Abrdn Life Sciences Investors pay dividends? What is the dividend yield for Abrdn Life Sciences Investors? Abrdn Life Sciences Investors announced a quarterly dividend on Friday, February 9th. Investors of record on Thursday, February 22nd will be paid a dividend of $0.39 per share on Thursday, March 28th. This represents a $1.56 annualized dividend and a yield of 12.03%. The ex-dividend date of this dividend is Wednesday, February 21st. This is a boost from the stock's previous quarterly dividend of $0.30. Read our dividend analysis for HQL. Is Abrdn Life Sciences Investors a good dividend stock? Abrdn Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.33 per share and currently has a dividend yield of 10.14%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL. What ETFs hold Abrdn Life Sciences Investors' stock? ETFs with the largest weight of Abrdn Life Sciences Investors (NYSE:HQL) stock in their portfolio include Saba Closed-End Funds ETF (CEFS).First Trust Income Opportunities ETF (FCEF). What other stocks do shareholders of Abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abrdn Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY). Who are Abrdn Life Sciences Investors' major shareholders? Abrdn Life Sciences Investors' stock is owned by a number of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.65%), Raymond James Financial Services Advisors Inc. (0.60%), 180 Wealth Advisors LLC (0.51%), Blue Bell Private Wealth Management LLC (0.12%), Atlantic Union Bankshares Corp (0.12%) and Eudaimonia Partners LLC (0.04%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead, Kathleen Goetz, Saba Capital Management, LP and Todd Reit. View institutional ownership trends. How do I buy shares of Abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HQL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.